ArticleMedicine2026
U-shaped association between neutrophil-percentage-to-albumin ratio and all-cause mortality in adults with hyperlipidemia: A prospective cohort study of NHANES 1999 to 2018.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hyperlipidemia impacts global mortality, and the neutrophil-percentage-to-albumin ratio (NPAR) is a novel inflammatory marker, but its association with mortality in hyperlipidemic adults is unknown. Using National Health and Nutrition Examination Survey data (1999-2018), this study examined NPAR's association with all-cause and cardiovascular disease (CVD) mortality in hyperlipidemic adults via multivariate Cox models and restricted cubic splines, with threshold effects and subgroup analyses also evaluated. Among 35,356 participants, NPAR showed a U-shaped link with all-cause mortality (inflection = 11.7; hazard ratio (HR) = 0.94, 95% confidence interval (CI) 0.91-0.98 below; HR = 1.14, 95% CI, 1.12-1.15 above) and a positive linear association with CVD mortality (HR = 1.12, 95% CI, 1.10-1.15). The all-cause mortality risk from higher NPAR was greater in physically inactive individuals. Among US adults with hyperlipidemia, a U-shaped association was identified between NPAR and all-cause mortality, while a linear positive correlation was noted with CVD mortality. An NPAR of 11.7 may be optimal, and physical activity might reduce risks from higher NPAR levels. NPAR may help identify high-risk patients for closer monitoring and targeted prevention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.